Kingdon Capital Management’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
Other funds holding ELDN
Kingdon Capital Management's ELDN Position: Q3 2026 in Review
Kingdon Capital Management sold out of Eledon Pharmaceuticals (ELDN) in Q3 2026, closing a stake of 1,039,275 shares — an estimated $4.09M sold.
Kingdon Capital Management first reported a position in ELDN in Q3 2014 and held it in 9 quarters. The position peaked at $9.9M in Q2 2015. 155 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.
- Kingdon Capital Management reported no remaining Eledon Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Kingdon Capital Management sold 1,039,275 Eledon Pharmaceuticals shares in Q3 2026, an estimated $4.09M.
- Kingdon Capital Management first reported a position in Eledon Pharmaceuticals in Q3 2014 and held it in 9 quarters.
- Kingdon Capital Management's Eledon Pharmaceuticals position peaked at $9.9M in Q2 2015.
- 155 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.
Based on Kingdon Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.